Supporting gentle ventilation of newborns

Monivent is a young medtech company dedicated to improve the care given to newborn babies in need of respiratory support at birth.

More about Monivent

IPO

Första dag för handel på Spotlight Stock Market planeras till den 17 mars 2020.


What we do

What we do

About 3 to 6 % of all newborns require manual ventilation support to start breathing.

Being one of the most important interventions performed in the delivery room, it’s also a very delicate one where both under- and overventilation can seriously damage lungs and brain. Nonetheless, it is one of the least controlled interventions taking place in the delivery room – tidal volumes given are rarely monitored. Instead, the volumes given have to be estimated by the caregiver trusting his or her clinical experience.

Press & news